What does this research mean for the field?

COVID-19 is associated with newly diagnosed Hashimoto’s thyroiditis, particularly in older patients who experience fatigue and thyroid dysfunction. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This study aims to examine the link between COVID-19 and newly diagnosed Hashimoto’s thyroiditis in patients.

March 13, 2026Frontiers in EndocrinologyOpen Access

Emerging evidence from China indicates SARS- COV-2 may be associated with newly diagnosed Hashimoto’s thyroiditis: a clinical study of 54 patients with COVID-19 complicated by newly diagnosed disease

View Full Paper

Ask AI

Bookmark

Authors

JHJingyu Hou YZYu Zhang BZBoyu Zhang

Discussion

Member takes

Overview

Clinical study shows COVID-19 patients have higher rates of Hashimoto's thyroiditis, indicating clinical implications for management.

Key Points

This study aims to examine the link between COVID-19 and newly diagnosed Hashimoto’s thyroiditis in patients.
Enrolled 369 COVID-19 patients and divided into three groups: Negative for Antibodies, Hashimoto’s Thyroiditis, and Thyroid Autoimmune.
Conducted clinical characteristic analysis of the Hashimoto’s Thyroiditis group.
Utilized SPSS 27.0 for data analysis.
HT group patients were older compared to NA group (median age 72.5 vs. 69 years, P = 0.031).
Fatigue reported more frequently in the HT group (53.7%) than in both TA (22.2%) and NA (24.0%) groups, P<0.001.
Subclinical hyperthyroidism and hypothyroidism occurred more in the HT group (29.6% vs. 13.9%; 7.4% vs. 1.7%, respectively, with P<0.05).
Prolonged viral clearance identified as a risk factor for COVID-19 complicated by HT.

Cite This Study

Hou et al. (2026) studied this question.

synapsesocial.com/papers/69b3aaa802a1e69014ccb68d https://doi.org/10.3389/fendo.2026.1749196

View Full Paper

Ask AI

Bookmark

March 13, 2026Frontiers in EndocrinologyOpen Access

Emerging evidence from China indicates SARS- COV-2 may be associated with newly diagnosed Hashimoto’s thyroiditis: a clinical study of 54 patients with COVID-19 complicated by newly diagnosed disease

View Full Paper

Ask AI

Bookmark

Authors

JHJingyu Hou YZYu Zhang BZBoyu Zhang

Discussion

Member takes

Overview

Clinical study shows COVID-19 patients have higher rates of Hashimoto's thyroiditis, indicating clinical implications for management.

Key Points

This study aims to examine the link between COVID-19 and newly diagnosed Hashimoto’s thyroiditis in patients.
Enrolled 369 COVID-19 patients and divided into three groups: Negative for Antibodies, Hashimoto’s Thyroiditis, and Thyroid Autoimmune.
Conducted clinical characteristic analysis of the Hashimoto’s Thyroiditis group.
Utilized SPSS 27.0 for data analysis.
HT group patients were older compared to NA group (median age 72.5 vs. 69 years, P = 0.031).
Fatigue reported more frequently in the HT group (53.7%) than in both TA (22.2%) and NA (24.0%) groups, P<0.001.
Subclinical hyperthyroidism and hypothyroidism occurred more in the HT group (29.6% vs. 13.9%; 7.4% vs. 1.7%, respectively, with P<0.05).
Prolonged viral clearance identified as a risk factor for COVID-19 complicated by HT.

Cite This Study

Hou et al. (2026) studied this question.

synapsesocial.com/papers/69b3aaa802a1e69014ccb68d https://doi.org/10.3389/fendo.2026.1749196

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark